Galmed Pharmaceuticals Ltd. (GLMD)
↓ Download CSV- Sector Manufacturing
- Incorporated L3
- Fiscal year ends Dec 31
Key ratios (FY2025)
43.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | $0 | $2.04M | $1.08M | $467.0K |
| Operating Income | — | — | — | — | — | -$30.21M | -$22.38M | -$10.71M | -$12.36M | — |
| Net Income | $6.90M | $7.50M | $10.30M | $17.90M | $32.40M | -$28.80M | $20.50M | -$9.86M | -$12.30M | -$16.95M |
| EPS (Diluted) | $2.39 | $8.08 | $30.00 | $127.80 | $19.80 | $1.35 | $0.97 | — | — | — |
| Total Assets | $18.63M | $18.50M | $16.63M | $16.56M | $36.60M | $52.38M | $77.14M | $90.60M | $19.64M | $16.45M |
| Shareholders' Equity | $15.78M | $16.33M | $13.88M | $13.42M | $30.50M | $44.15M | $69.85M | $87.89M | $15.79M | $11.07M |
| Cash & Equivalents | $3.98M | $4.65M | $2.86M | $2.02M | $2.88M | $6.95M | $15.93M | $24.16M | $13.02M | $3.10M |
| Operating Cash Flow | -$6.32M | -$5.88M | -$6.14M | -$18.50M | -$32.89M | -$26.29M | -$14.94M | -$9.02M | -$12.07M | -$12.13M |
| Capital Expenditures | — | — | — | $4.0K | $11.0K | $44.0K | $12.0K | $90.0K | $12.0K | $17.0K |
| Shares Outstanding | 6.58M | 1.66M | 573.7K | 1.69M | 25.09M | 21.33M | 21.14M | 21.02M | 14.44M | 12.15M |